Physician

John Stewart O'Keefe, M.D.

According to 2025 Medicare claims, John O'Keefe, M.D. (NPI: 1073576377) practices ophthalmology in the Richmond, VA market, with the plurality of this provider's patient population coming from Henrico, VA. This provider's primary affiliated billing organization is VIRGINIA EYE CONSULTANTS INC (NPI: 1992727820; TIN: 541150779) and primary practice location at 23235-1989.

O'Keefe's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,754 traditional Medicare patients, billed 45,417 HCPCS/CPT codes, and received $5,326,452 in Medicare payments. The top billing code was J0178 (Injection, aflibercept, 1 mg). Part D data shows 997 prescription claims across 302 beneficiaries totaling $39,963 in drug costs, led by Prednisolone Acetate (Prednisolone Acetate). Open Payments data shows 1 records totaling $90. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $2,983,375 to $5,326,452. Concurrently, Part D prescription costs did not follow a clear longitudinal pattern. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$2.7M$5.3M2015 Medicare payment: $2,983,375 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $3,177,095 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $3,644,081 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $4,107,856 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $4,899,235 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $4,892,859 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $4,936,580 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $4,800,763 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $4,874,892 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $5,326,452 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20151,60214,766$2,983,375
20161,71315,753$3,177,095
20171,78316,795$3,644,081
20181,81317,660$4,107,856
20191,83319,176$4,899,235
20201,67417,821$4,892,859
20211,62017,130$4,936,580
20221,65416,661$4,800,763
20231,67623,244$4,874,892
20241,75445,417$5,326,452

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$29K$58K2015 Drug cost: $37,186 (USD; Tot_Drug_Cst)2016 Drug cost: $37,198 (USD; Tot_Drug_Cst)2017 Drug cost: $38,530 (USD; Tot_Drug_Cst)2018 Drug cost: $57,311 (USD; Tot_Drug_Cst)2019 Drug cost: $57,623 (USD; Tot_Drug_Cst)2020 Drug cost: $49,731 (USD; Tot_Drug_Cst)2021 Drug cost: $54,258 (USD; Tot_Drug_Cst)2022 Drug cost: $57,903 (USD; Tot_Drug_Cst)2023 Drug cost: $48,305 (USD; Tot_Drug_Cst)2024 Drug cost: $39,963 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015198707$37,186
2016219729$37,198
2017221711$38,530
2018254855$57,311
2019218751$57,623
2020214683$49,731
2021221749$54,258
2022262803$57,903
2023242867$48,305
2024302997$39,963

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
J0178Injection, aflibercept, 1 mg4344,662$657
67028Injection of drug into eye7103,193$99
92014Established patient complete exam of visual system1,3141,688$90
92134Imaging of retina7192,024$30
92250Photography of the retina1,3562,602$28

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Prednisolone AcetatePrednisolone Acetate1446,070$5,674
Brimonidine TartrateBrimonidine Tartrate754,203$4,682
Lotemax SmLoteprednol Etabonate13335$3,261
Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat1469,816$2,471
Loteprednol EtabonateLoteprednol Etabonate11319$2,304

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.1$90Astellas Pharma US Inc
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for John Stewart O'Keefe, M.D.?

Tedicare shows public-source Medicare data for John Stewart O'Keefe, M.D. (NPI 1073576377), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does John Stewart O'Keefe, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to John Stewart O'Keefe, M.D.?

John Stewart O'Keefe, M.D. is linked to VIRGINIA EYE CONSULTANTS INC (billing NPI 1992727820) in the available physician profile data.

Does John Stewart O'Keefe, M.D. have Open Payments data?

John Stewart O'Keefe, M.D. has 1 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.